9:50am ET
Health and Healthcare
Where Merck and Pfizer’s Type 2 Diabetes Treatment Can Go From Here
Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type 2 diabetes treatment.
Companies
/Healthcare
Merck & Co Inc
$143.93
▼ $0.78 (−0.54%) today
Markets closed · 1:50pm ET
MRK Coverage
Page 358:55am ET
Health and Healthcare
Why Short Sellers Are Making a Massive Bet in Major Pharma
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
12:10pm ET
Health and Healthcare
Merck Delivers Even More Disappointing News in Alzheimer’s Study
Merck saw its shares slip on Wednesday after the firm reported that it will be halting its mid-to-late-stage clinical trial for the treatment of Alzheimer’s disease.
Chris Lange 4:01pm ET
Investing
Apple, JPMorgan Dominate DJIA on Tuesday
JPMorgan, Apple, Merck, and Goldman Sachs all set new 52-week highs and dominated the rising DJIA on Tuesday.
8:35am ET
Health and Healthcare
Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?
It has yet to be seen how much headway Trump can actually make with heath care reforms, but so far the reaction has been quite positive.
9:05am ET
Health and Healthcare
Why Merck’s Q4 Earnings Aren’t Enough for Investors
Merck reported disappointing fourth-quarter financial results before the markets opened on Thursday.
Chris Lange 12:05pm ET
Investing
The Top 2 Dow Stocks Reporting on Thursday
24/7 Wall St. has put together a preview of the two Dow stocks scheduled to report their quarterly results on Thursday: Merck and Visa.
10:25am ET
Investing
What to Expect From Dow Stocks Reporting This Week
Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the index has made since the Trump rally began and push it even…
9:50am ET
Health and Healthcare
Short Sellers Run for Cover From Major Pharma
The January 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mostly down.
4:01pm ET
Investing
GE, Exxon, Boeing Sink DJIA on Monday
GE, Merck, Boeing, and Exxon Mobil lead the DJIA to a small loss on Monday.
4:01pm ET
Investing
Merck, P&G Lead Dow Stocks Higher Friday
Merck, P&G, IBM, and Exxon Mobil lift DJIA by more than 75 points on Friday.
4:01pm ET
Investing
Exxon Mobil, Merck Weigh on DJIA Thursday
Exxon Mobil, Merck, Goldman Sachs, and Pfizer sink the DJIA on Thursday.
10:15am ET
Health and Healthcare
Merck Is Best Performing DJIA Stock So Far in 2017
Oddly, perhaps, the best performing stock in the first two weeks of the year is drug maker Merck.
Paul Ausick 1:20pm ET
Health and Healthcare
Why 3 Analysts Upgraded Merck Simultaneously
The the attacks against drug pricing and competition do not seem to be going away, but somehow, Merck has managed to find itself as a top pick for pharmaceutical and biohealth analysts.
Jon C. Ogg 10:50am ET
Health and Healthcare
Major Pharma Short Interest Declines Ahead of Trump Comments
The short interest data have been released for the December 30 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials.